Jonathan A Fletcher

7PUBLICATIONS
88CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 27, 2026
Correction: Song et al. AXL Inactivation Inhibits Mesothelioma Growth and Migration via Regulation of p53 Expression. Cancers 2020, 12, 2757.

|Feb 26, 2024
KIT ATP-Binding Pocket/Activation Loop Mutations in GI Stromal Tumor: Emerging Mechanisms of Kinase Inhibitor Escape.

Thomas Mühlenberg, Johanna Falkenhorst, Tom Schulz

|Sep 29, 2023
Hyper-Dependence on NHEJ Enables Synergy between DNA-PK Inhibitors and Low-Dose Doxorubicin in Leiomyosarcoma.

Adrian Marino-Enriquez, Jan Philipp Novotny, Doga C Gulhan

|Jul 05, 2022
PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.

Amish J Patel, Sarah Warda, Jesper L V Maag

|Jun 18, 2021
E3 ligase MKRN3 is a tumor suppressor regulating PABPC1 ubiquitination in non-small cell lung cancer.

Ke Li, Xufen Zheng, Hua Tang

|May 05, 2021
YWHAE-NUTM2 oncoprotein regulates proliferation and cyclin D1 via RAF/MAPK and Hippo pathways.

Wen-Bin Ou, Meijun Z Lundberg, Shuihao Zhu

Pageof 2

Frequent Collaborators

4 joint publications

Wen-Bin Ou

3 joint publications

Adrian Mariño-Enriquez

2 joint publications

Daniel Rauh

2 joint publications

Thomas Mühlenberg